2-Butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1H-imidazole-5-carboxylic acid(CAS: 124750-92-1)

The compound is subject to regulations such as REACH in the EU, which requires registration and reporting of substances above one tonne per year. It also falls under the scope of GHS for classification and labeling. In the USA, FDA and EPA may require documentation for import, use, and disposal of the compound.

Alternative reagents and synthetic routes can include using different starting materials or modifying the reaction conditions. For example, other imidazole derivatives or tetrazoles can be explored as substitutes based on the specific application and desired properties.

The compound is primarily used in research and development, with trends showing increased interest in its application in pharmaceuticals. Market trends indicate a focus on its use as an intermediate or active pharmaceutical ingredient (API), with a growing emphasis on its therapeutic potential.

Waste containing the compound should be collected in appropriate containers and stored separately. Proper incineration or professional waste disposal services should be utilized to ensure safe disposal. Environmental protection measures include monitoring for any potential leaching and adherence to local waste management regulations.